MicroRNA-409-3p functions as a tumor suppressor in human lung adenocarcinoma by targeting c-Met

Cellular Physiology and Biochemistry

Volumn 34, Issue 4, 2014, Pages 1273-1290

  Wan, Li ^a   Zhu, Lingjun ^a   Xu, Jianghao ^a   Lu, Binbin ^a   Yang, Yucai ^a   Liu, Fengzhen ^a   Wang, Zhaoxia ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

c Met; Lung adenocarcinoma; miR 409 3p; Prognosis; Tumor suppressor

Indexed keywords

GELATINASE A; GELATINASE B; MICRORNA; MICRORNA 400 39; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; SCATTER FACTOR RECEPTOR; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; MIRN409 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; A549 CELL LINE; ADULT; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER PROGNOSIS; CANCER STAGING; CELL MIGRATION; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUNG ADENOCARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECURRENCE FREE SURVIVAL; RNA ISOLATION; SIGNAL TRANSDUCTION; TUMOR DIFFERENTIATION; TUMOR INVASION; TUMOR SUPPRESSOR GENE; UPREGULATION; WESTERN BLOTTING; WOUND HEALING; ADENOCARCINOMA; CELL DIFFERENTIATION; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; TUMOR CELL LINE;

ADENOCARCINOMA; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE; CELL LINE, TUMOR; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-MET; SIGNAL TRANSDUCTION;

EID: 84908619044     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000366337     Document Type: Article

References (35)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-249.
2. Gettinger S, Lynch T: A decade of advances in treatment for advanced non-small cell lung cancer. Clin Chest Med 2011;32:839-851.
3. Schrump DS, Nguyen DM: Targets for molecular intervention in multistep pulmonary carcinogenesis. World J Surg 2001;25:174-183.
4. Shivdasani RA: MicroRNAs: regulators of gene expression and cell differentiation. Blood 2006;108:3646-3653.
5. Pillai RS, Bhattacharyya SN, Filipowicz W: Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol 2007;17:118-126.
6. Donadeu FX, Schauer SN, Sontakke SD: Involvement of miRNAs in ovarian follicular and luteal development. J Endocrinol 2012;215:323-334.
7. Liwak U, Faye MD, Holcik M: Translation control in apoptosis. Exp Oncol 2012;34: 218-230.
8. Rutnam ZJ, Yang BB: The involvement of microRNAs in malignant transformation. Histol Histopathol 2012;27:1263-1270.
9. Farazi TA, Hoell JI, Morozov P, Tuschl T: MicroRNAs in human cancer. Adv Exp Med Biol 2013;774:1-20.
10. Xie L, Yang Z, Li G, Shen L, Xiang X, Liu X, Xu D, Xu L, Chen Y, Tian Z, Chen X: Genome-wide identification of bone metastasis-related microRNAs in lung adenocarcinoma by high-throughput sequencing. PLoS One 2013;8:e61212.
11. Patnaik SK, Yendamuri S, Kannisto E, Kucharczuk JC, Singhal S, Vachani A: MicroRNA expression profiles of whole blood in lung adenocarcinoma. PLoS One 2012;7:e46045.
12. Zhang H, Su Y, Xu F, Kong J, Yu H, Qian B: Circulating MicroRNAs in Relation to EGFR Status and Survival of Lung Adenocarcinoma in Female Non-Smokers. PLoS One 2013;8:e81408.
13. Xu X, Chen H, Lin Y, Hu Z, Mao Y, Wu J, Xu X, Zhu Y, Li S, Zheng X, Xie L: MicroRNA-409-3p inhibits migration and invasion of bladder cancer cells via targeting c-Met. Mol Cell 2013;36:62-68.
14. Li C, Nie H, Wang M, Su L, Li J, Yu B, Wei M, Ju J, Yu Y, Yan M, Gu Q, Zhu Z, Liu B: MicroRNA-409-3p regulates cell proliferation and apoptosis by targeting PHF10 in gastric cancer. Cancer Lett 2012;320:189-197.
15. Weng C, Dong H, Chen G, Zhai Y, Bai R, Hu H, Lu L, Xu Z: miR-409-3p inhibits HT1080 cell proliferation, vascularization and metastasis by targeting angiogenin. Cancer Lett 2012;323:171-179.
16. Goetsch L, Caussanel V, Corvaia N: Biological significance and targeting of c-Met tyrosine kinase receptor in cancer. Front Biosci (Landmark Ed) 2013;18:454-473.
17. Cecchi F, Rabe DC, Bottaro DP: Targeting the HGF/Met signalling pathway in cancer. Eur J Cancer 2010;46:1260-1270.
18. Nam HJ, Chae S, Jang SH, Cho H, Lee JH: The PI3K-Akt mediates oncogenic Met-induced centrosome amplification and chromosome instability. Carcinogenesis 2010;31:1531-1540.
19. Chen PS, Su JL, Hung MC: Dysregulation of microRNAs in cancer. J Biomed Sci 2012;19:90.
20. Minna JD, Fong K, Zöchbauer-Müller S, Gazdar AF: Molecular pathogenesis of lung cancer and potential translational applications. Cancer J 2002;8:S41-46.
21. Kitamura K, Seike M, Okano T, Matsuda K, Miyanaga A, Mizutani H, Noro R, Minegishi Y, Kubota K, Gemma A: MiR-134/487b/655 Cluster Regulates TGF-ß-induced Epithelial-Mesenchymal Transition and Drug Resistance to Gefitinib by Targeting MAGI2 in Lung Adenocarcinoma Cells. Mol Cancer Ther 2013 Dec 9. [Epub ahead of print]
22. Zhao C, Xu Y, Zhang Y, Tan W, Xue J, Yang Z, Zhang Y, Lu Y, Hu X: Downregulation of miR-145 contributes to lung adenocarcinoma cell growth to form brain metastases. Oncol Rep 2013;30:2027-2034.
23. Xiang Q, Tang H, Yu J, Yin J, Yang X, Lei X: MicroRNA-98 sensitizes cisplatin-resistant human lung adenocarcinoma cells by up-regulation of HMGA2. Pharmazie 2013;68:274-281.
24. Liu YJ, Lin YF, Chen YF, Luo EC, Sher YP, Tsai MH, Chuang EY, Lai LC: MicroRNA-449a enhances radiosensitivity in CL1-0 lung adenocarcinoma cells. PLoS One 2013;8:e62383.
25. Li C, Nie H, Wang M, Su L, Li J, Yu B, Wei M, Ju J, Yu Y, Yan M, Gu Q, Zhu Z, Liu B: MicroRNA-409-3p regulates cell proliferation and apoptosis by targeting PHF10 in gastric cancer. Cancer Lett 2012;320:189-197.
26. Nadal E, Zhong J, Lin J, Reddy RM, Ramnath N, Orringer MB, Chang AC, Beer DG, Chen G: A MicroRNA cluster at 14q32 drives aggressive lung adenocarcinoma. Clin Cancer Res 2014;20:3107-17.
27. Porter AC, Vaillancourt RR: Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis. Oncogene 1998;17:1343-1352.
28. Lowery FJ, Yu D: Growth factor signaling in metastasis: current understanding and future opportunities. Cancer Metastasis Rev 2012;31:479-491.
29. Grzelakowska-Sztabert B, Dudkowska M: Paradoxical action of growth factors: antiproliferative and proapoptotic signaling by HGF/c-MET. Growth Factors 2011;29:105-118.
30. Shawna Leslie Organ: An overview of the c-MET signaling pathway. Ther Adv Med Oncol 2011;3:S7-S19.
31. Yi S, Tsao MS: Activation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line. Neoplasia 2000;2:226-234.
32. Stabile LP, Lyker JS, Land SR, Dacic S, Zamboni BA, Siegfried JM: Transgenic mice overexpressing hepatocyte growth factor in the airways show increased susceptibility to lung cancer. Carcinogenesis 2006;27:1547-1555.
33. Tokunou M, Niki T, Eguchi K, Iba S, Tsuda H, Yamada T, Matsuno Y, Kondo H, Saitoh Y, Imamura H, Hirohashi S: c-MET expression in myofibroblasts: role in autocrine activation and prognostic significance in lung adenocarcinoma. Am J Pathol 2001;158:1451-1463.
34. Luo W, Huang B, Li Z, Li H, Sun L, Zhang Q, Qiu X, Wang E: MicroRNA-449a is downregulated in non-small cell lung cancer and inhibits migration and invasion by targeting c-Met. PLoS One 2013;8:e64759.
35. Thomson DW, Bracken CP, Goodall GJ: Experimental strategies for microRNA target identification. Nucleic Acids Res 2011;39:6845-6853.